TTD | Drug: D0B2NF

Drug General Information
Drug ID	D0B2NF
Former ID	DIB009606
Drug Name	AEB701
Indication	Melanoma [ICD9: 172; ICD10:C43]		Phase 1	[551507]
Target and Pathway
Target(s)	Protein kinase C	Target Info	Inhibitor	[550085]
References
Ref 551507	Nearly 800 Medicines and Vaccines in Clinical Testing For Cancer Offer New Hope to Patients. Pharmaceutical Research and Manufacturers of America report. 2014.
Ref 550085	Changes in Serum Cytokine Profile after AEB071 (Sotrastaurin) or Tacrolimus versus Their Combinations in Rat Heterotopic Cardiac Allografts. J Korean Soc Transplant. 2012 Dec;26(4):248-253.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.

Drug Information